Most Read Articles
Stephen Padilla, 4 days ago
Diabetic patients in a decompensated state and who develop type 2 myocardial infarction (MI) have an increased risk for mortality and major adverse cardiac events (MACE), according to a new study. In addition, these patients are potentially at risk for undiagnosed coronary artery disease.
6 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 13 Jul 2018
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.
6 days ago
Switching from thiazide diuretic to ipragliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, leads to improvements in metabolic parameters and body mass composition without affecting blood pressure in type 2 diabetes (T2D) patients, a recent study has found.

Cycling does not adversely affect sexual, urinary function in females

07 Apr 2018
A study suggests that working out intensely for a minute three times a week will provide the same benefits as a longer, endurance training.

Female cyclists do not have significantly worse urinary or sexual function compared with other athletes, a recent study has shown. However, other genitourinary conditions, such as saddle sores and genital numbness, are associated with cycling and may lead to sexual dysfunction.

Using Facebook advertisements and outreach to sporting clubs, researchers recruited 1,656 low-intensity cyclists and 409 high-intensity cyclists, who were asked to accomplish a survey. Swimmers and runners (n=1,053) were recruited as noncyclist controls. Study outcomes included responses to different validated questionnaires, such as the Female Sexual Function Index (FSFI) and the American Urological Association Symptom Index.

Interestingly, both high-intensity (mean score, 23.1 points; p<0.001) and low-intensity (mean score, 22.6 points; p<0.001) cyclists had significantly higher mean FSFI scores than noncyclists (mean score, 20.8). Results in the arousal, lubrication, orgasm and satisfaction domains were significantly better for both cyclist groups.

The high-intensity and low-intensity cyclist groups also had significantly lower odds of reporting sexual dysfunction than controls (odds ratio [OR], 0.6; 0.5–0.8; p<0.001 and OR, 0.8; 0.6–0.9; p<0.001, respectively).

After multivariable adjustment, statistical significance was attenuated such that low-intensity and high-intensity cyclists had mean FSFI scores similar to noncyclist controls. High-intensity cyclists remained significantly less likely to report sexual dysfunction than controls (OR, 0.7; 0.6–0.95; p=0.02).

In contrast, both cyclist respondent groups showed significantly higher odds of reporting previous urinary tract infection, perineal numbness and saddle sores, as compared with swimmers or runners.

Across all analyses performed, no significant differences in urinary symptoms were reported across all groups.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 4 days ago
Diabetic patients in a decompensated state and who develop type 2 myocardial infarction (MI) have an increased risk for mortality and major adverse cardiac events (MACE), according to a new study. In addition, these patients are potentially at risk for undiagnosed coronary artery disease.
6 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 13 Jul 2018
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.
6 days ago
Switching from thiazide diuretic to ipragliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, leads to improvements in metabolic parameters and body mass composition without affecting blood pressure in type 2 diabetes (T2D) patients, a recent study has found.